|1||NCT00657007||Completed||Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)||
||70||All||18 Years and older (Adult, Senior)||NCT00657007||LBSL01
Partial NIH grant M01 RR 00043
|February 2002||March 2003||March 2003||April 14, 2008||August 2, 2013||
|2||NCT01142011||Unknown †||A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia||
||Other / Industry||
||15||All||18 Years and older (Adult, Senior)||NCT01142011||HGSI Belimumab in WM||November 2009||June 2012||January 2013||June 11, 2010||February 10, 2012||
† Study has passed its completion date and status has not been verified in more than two years.